Targeting the p27 E3 ligase SCF Skp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy by Qing Chen, Weilin Xie, Deborah.

Slides:



Advertisements
Similar presentations
Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
Advertisements

A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies by Jutta Deckert, Peter U. Park,
RA190 Small Molecule Proteasome Inhibitor for Cancer Therapy.
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas by Amrita Krishnan, Arturo Molina, John Zaia, David.
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target by Francis Mussai, Sharon Egan, Joseph Higginbotham-Jones,
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma by Joshua Richter, Natalia Neparidze,
Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways.
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.
CD8 + T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia by Li Ma, Elisa Simpson,
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
Pathogenesis beyond the cancer clone(s) in multiple myeloma by Giada Bianchi, and Nikhil C. Munshi Blood Volume 125(20): May 14, 2015 ©2015 by.
Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid–based proteasome inhibitors by Encouse B. Golden, Philip Y. Lam,
Uncontrolled Wnt signaling causes leukemia
The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells by Changchun.
Triple play of H pylori in ITP
Multiple Myeloma: Interleukin-15 Antagonizes Bone Morphogenetic Protein-Induced Apoptosis and Growth Inhibition. by Magne Rekvig, Anne-Tove Brenne, Torstein.
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma by Nicolaus Kröger,
Positioning NK-κB in multiple myeloma
Next-generation leukemia immunotherapy
An endothelial metronome breast cancer?
When monocyte life hangs by a thread
It's all in the timing by Linda J. Bendall Blood
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma by Lotta.
Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy by Qing Chen, Weilin Xie, Deborah J.
BTK inhibition in myeloma: targeting the seed and the soil
Tax fingerprint in adult T-cell leukemia
The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and.
How I treat elderly patients with myeloma
Mechanisms of HIV-associated lymphocyte apoptosis
by Satish Gopal, William A. Wood, Stephanie J. Lee, Thomas C
Topical Sodium Nitrite Is Effective In Reducing Leg Ulcer-Associated Pain In Patients With Sickle Cell Disease by Caterina P. Minniti, Caroline Cantilena,
Skovseth et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood.
Another Piece of the p27Kip1 Puzzle
Genetic sequence analysis of inherited bleeding diseases
by Jonathan N. Hofmann, Linda M. Liao, Michael N
A phase 2 study of single-agent carfilzomib (PX A1) in patients with relapsed and refractory multiple myeloma by David S. Siegel, Thomas Martin,
Taking a leaf from the book of oral tolerance
Has the T cell bitten off more than it can chew?
Rare cells predict GVHD
Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma by Rishi K.
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Ph+ ALL: drawing strength from a benign past
Bone Turnover Biomarkers Are Useful In Monitoring Myeloma Bone Disease and As Early Predictor Biomarkers For Relapse Disease In Multiple Myeloma by Kay.
Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813. Blood Volume 114(14): October.
Anergy: the CLL cell limbo
A new red cell shape helps the clot
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Proteaphagy—Selective Autophagy of Inactive Proteasomes
Richard G. Carroll, Seamus J. Martin  Cancer Cell 
The SCF Ubiquitin Ligase
by Santosh L. Saraf, Xu Zhang, Tamir Kanias, James P. Lash, Robert E
by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc
SCD-101: A New Anti-Sickling Drug Reduces Pain and Fatigue and Improves Red Blood Cell Shape in Peripheral Blood of Patients with Sickle Cell Disease by.
MRD detection in multiple myeloma: comparison between MSKCC 10-color single-tube and EuroFlow 8-color 2-tube methods by Mikhail Roshal, Juan A. Flores-Montero,
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma by Tomer M. Mark, Peter A. Forsberg, Adriana.
Overcoming “aspirin resistance” in MPN
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Sickle cells and sickle trait in thrombosis
Crashing waves of destruction
Schematic model of the mechanism of Tak1 protection of HSPC survival.
Bigger, Stronger, Faster: Chimeric Antigen Receptor T Cells Are Olympic Killers by Paul J Neeson, Alexander James Davenport, Joseph A Trapani, Michael.
The TRIP from ULF to ARF Cancer Cell
B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) for Multiple Myeloma (MM): Initial Safety and Efficacy from a Phase.
Rituximab immunotherapy: it’s getting personal
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
Disruption of Autophagy Blocks Autophagic Degradation of LDs
Patient Tregs express normal levels of suppression.
Presentation transcript:

Targeting the p27 E3 ligase SCF Skp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy by Qing Chen, Weilin Xie, Deborah J. Kuhn, Peter M. Voorhees, Antonia Lopez- Girona, Derek Mendy, Laura G. Corral, Veronique Plantevin Krenitsky, Weiming Xu, Laure Moutouh-de Parseval, David R. Webb, Frank Mercurio, Keiichi I. Nakayama, Keiko Nakayama, and Robert Z. Orlowski Blood Volume 111(9): May 1, 2008 ©2008 by American Society of Hematology

CpdA inhibits p27Kip1 ubiquitination and turnover. Qing Chen et al. Blood 2008;111: ©2008 by American Society of Hematology

Stabilization of SCFSkp2 substrates by CpdA in multiple myeloma cells. Qing Chen et al. Blood 2008;111: ©2008 by American Society of Hematology

SCFSkp2 inhibition induces caspase-independent apoptosis and cell-cycle arrest. Qing Chen et al. Blood 2008;111: ©2008 by American Society of Hematology

Inhibition of SCFSkp2 induces autophagic cell death. Qing Chen et al. Blood 2008;111: ©2008 by American Society of Hematology

CpdA overcomes drug resistance and induces chemosensitization. Qing Chen et al. Blood 2008;111: ©2008 by American Society of Hematology

CpdA is active in patient-derived neoplastic cells. Qing Chen et al. Blood 2008;111: ©2008 by American Society of Hematology